The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
Open accessPublished version of a preprint
Abstract
The novel respiratory disease COVID-19 produces varying symptoms, with fever, cough, and shortness of breath being common. In older adults, we found that pre-existing dementia is a major risk factor (OR = 3.07, 95% CI: 1.71 to 5.50) for COVID-19 hospitalization in the UK Biobank (UKB). In another UK study of 16,749 patients hospitalized for COVID-19, dementia was among the common comorbidities and was associated with higher mortality. Additionally, impaired consciousness, including delirium, is common in severe cases. The ApoE e4 genotype is associated with both dementia and delirium, with the e4e4 (homozygous) genotype associated with high risk of dementia. We therefore aimed to test associations between ApoE e4 alleles and COVID-19 severity, using the UKB data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, individuals with the ApoE3 allele may be more susceptible to severe forms of COVID-19 disease [183].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Miao, X., Hu, Y., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.02.22.20026500 · Cited by 909
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa183 · Cited by 497
Self-citationDocherty, A., Harrison, E., Green, C. A., et al. (2020) · medRxiv · doi:10.1101/2020.04.23.20076042 · Cited by 416
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
Self-citationTudorache, I. F., Trusca, V. G., & Gafencu, A. V. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.05.003 · Cited by 186
Armstrong, J., Rudkin, J., Allen, N. E., Crook, D. W., Wilson, D. J., Wyllie, D. H., & O’Connell, A. M. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000397 · Cited by 129
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 386
Angulo-Aguado, M., Carrillo-Martínez, J. C., Contreras-Bravo, N. C., Morel, A., Abaunza, K. P., Usaquén, W., Fonseca, D. J., & Ortega‐Recalde, O. (2024) · Scientific Reports · doi:10.1038/s41598-024-57982-3 · Cited by 13
Current opinion in neurological manifestations of SARS-CoV-2 infection
Engin, A. B., Engin, A., & Engin, A. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.03.004 · Cited by 11
DeepHisCoM: deep learning pathway analysis using hierarchical structural component models
Park, C., Kim, B., & Park, T. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac171 · Cited by 12
Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Ramachandran, A. K., Das, S., & Joseph, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210113154342 · Cited by 12
Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection
Alemán, G. G., Vavougios, G. D., Tartaglia, M. C., Uvais, N. A., Guekht, A. B., Hosseini, A. A., Re, V. L., Catterina Ferreccio, R., d’Avossa, G., Zamponi, H. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1432357 · Cited by 15
Vologzhanin, D. A., Голота, А. С., Kamilova, Т. A., Shneider, O. V., & Sherbak, S. G. (2021) · Journal of clinical practice · doi:10.17816/clinpract64972 · Cited by 11
Sharma, S. K. (2021) · Annals of Neurosciences · doi:10.1177/09727531211009420 · Cited by 12
Barmania, F., Mellet, J., Ryder, M. A., Ford, G., Herd, C. L., Tamuhla, T., Hendricks, C., Giles, R., Kalua, T., Joubert, F., et al. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01089-8 · Cited by 7
Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
Xu, Z., Wang, H., Jiang, S., Teng, J., Zhou, D., Chen, Z., Wen, C., & Xu, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01110-0 · Cited by 10
Ahmetov, I. I., Borisov, O., Semenova, E. A., Andryushchenko, O. N., Andryushchenko, L. B., Generozov, E. V., & Pickering, C. (2020) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.07.010 · Cited by 11
Maniero, C., Patel, D., Pavithran, A., Naran, P., Ng, F. L., Prowle, J. R., & Sivapathasuntharam, D. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02679-z · Cited by 11
David, S., Dorado, G., Duarte, E. L., David-Bosne, S., Trigueiro-Louro, J. M., & Rebelo‐de‐Andrade, H. (2022) · Immunogenetics · doi:10.1007/s00251-022-01261-w · Cited by 13
ApoE4 causes severe COVID-19 outcomes via downregulation of ACE2Preprint
Chen, F., Chen, Y., Ke, Q., Wang, Y., Chen, X., Peng, X., Cai, Y., Li, S., Sun, Y., Ji, Y., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.04.506474 · Cited by 11
Modeling infectious diseases of the central nervous system with human brain organoids
Priyathilaka, T. T., Laaker, C. J., Herbáth, M., Fábry, Z., & Sándor, M. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.013 · Cited by 11
The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment
Захаров, Д. В., & Buriak, I. V. (2021) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2021-57-4-97-105 · Cited by 10
Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19
Pomara, N., & Imbimbo, B. P. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110274 · Cited by 10
Biological Factors Linking ApoE ε4 Variant and Severe COVID-19
Inal, J. M. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00896-y · Cited by 10
Azizur, R., Saidur, R., & Nur, A. (2020) · Annals of Alzheimer s and Dementia Care · doi:10.17352/aadc.000015 · Cited by 9
Tsiakiri, A., Vlotinou, P., Terzoudi, A., Heliopoulos, I., & Vadikolias, Κ. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220118 · Cited by 9
Alzheimer’s Disease and SARS-CoV-2: Pathophysiological Analysis and Social Context
Ortíz, G. G., Velázquez-Brizuela, I. E., Ortiz-Velázquez, G. E., Ocampo-Alfaro, M. J., Flores, J. S., Delgado-Lara, D. L. C., & Torres-Sánchez, E. D. (2022) · Brain Sciences · doi:10.3390/brainsci12101405 · Cited by 9
Sifuentes‐Osornio, J., Angulo‐Guerrero, O., de Anda‐Jáuregui, G., Díaz-de-Léon-Santiago, J. L., Lemus, E. H., Benítez‐Pérez, H., Herrera, L. A., Arellano, O. L., Revuelta-Herrera, A., Rosales-Tapia, A. R., et al. (2022) · Journal of Global Health · doi:10.7189/jogh.12.05038 · Cited by 9
Fiorentino, G., Benincasa, G., Coppola, A., Franzese, M., Annunziata, A., Affinito, O., Viglietti, M., & Napoli, C. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02728-z · Cited by 9
Alghanem, B., Mansour, F. A., Shaibah, H., Almuhalhil, K., Almourfi, F. M., Alamri, H. S., Alajmi, H., Rashid, M., Alroqi, F. J., Jalouli, M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15224 · Cited by 9
Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?
Tavares-Júnior, J. W. L., Oliveira, D. N., da Silva, J. B. S., Feitosa, W. L. Q., Sousa, A. V. M., Marinho, S. C., Cunha, L. C. V., Gaspar, S. D. B., Gomes, C. M. P., de Oliveira, L. L. B., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13121611 · Cited by 10
Alzheimer's Disease and Suicide: An Integrative Literature Review
Rodrigues, J. F. R., Rodrigues, L. P., & Filho, G. M. D. A. (2023) · Current Alzheimer Research · doi:10.2174/0115672050292472240216052614 · Cited by 9
Host factors: Implications in immunopathogenesis of COVID-19
Jafarpour, R., Pashangzadeh, S., & Dowran, R. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153647 · Cited by 10
de Rojas, I., Hernández, I., Montrreal, L., Quintela, I., Calero, M., Royo, J. L., Vilas, R. H., González-Pérez, A., Macías, E. F., Macı́as, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121318 · Cited by 9
Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4
Lima, F. B., Bezerra, K. C., Nascimento, J. C. R., Meneses, G. C., & Oriá, R. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.721793 · Cited by 8
Villapalos‐García, G., Zubiaur, P., Rivas-Durán, R., Campos-Norte, P., Román, C. A., Fernández-Rico, M., Fraile, L. G.-F., Fernández-Campos, P., Soria‐Chacartegui, P., de Córdoba‐Oñate, S. F., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202201396 · Cited by 9
Association of Cancer with Risk and Mortality of COVID-19: Results from the UK BiobankPreprint
Shi, Z., Resurreccion, W. K., Wang, C., Wei, J., Na, R., Zheng, S., Billings, L. K., Helfand, B. T., Khandekar, J. D., & Xu, J. (2020) · medRxiv · doi:10.1101/2020.07.10.20151076 · Cited by 14
Reas, E. T., Alderson‐Myers, A., Solders, S. K., Shen, Q., Rivera, C. S., Wang, X., Stiver, J., Banks, S. J., & Graves, J. (2025) · Imaging Neuroscience · doi:10.1162/imag.a.23 · Cited by 11
Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection
Hariyanto, T. I., Putri, C., Situmeang, R. F. V., & Kurniawan, A. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.10.026 · Cited by 8
Hachem, M. (2021) · Biochimie · doi:10.1016/j.biochi.2021.02.012 · Cited by 8
Hsu, P.-C., & Shahed-Al-Mahmud, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120981 · Cited by 9
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases
Kryńska, K., Kuliś, K., Mazurek, W., Gudowska-Sawczuk, M., Zajkowska, M., & Mroczko, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168715 · Cited by 9
BIN1 rs744373 SNP and COVID‑19 mortality
Lehrer, S. P., & Rheinstein, P. H. (2021) · World Academy of Sciences Journal · doi:10.3892/wasj.2021.84 · Cited by 8
Classen, J. (2021) · Journal of Medical - Clinical Research & Reviews · doi:10.33425/2639-944x.1202 · Cited by 8
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
Bartolomé, F. B., Rosa, L., Valenti, P., Lopera, F. J., Hernández‐Gallego, J., Cantero, J. L., Orive, G., & Carro, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878201 · Cited by 8
Almasi, F., Dang, W., Mohammadipanah, F., & Li, N. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01420-3 · Cited by 8
Gait dysfunction in Alzheimer disease
Wısnıewskı, T., & Masurkar, A. V. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00013-2 · Cited by 8
Yazdanparast, S., Bakhtiyaridovvombaygi, M., Mikanik, F., Ahmadi, R., Ghorbani, M., Mansoorian, M. R., Mansoorian, M., Chegni, H., Moshari, J., & Gharehbaghian, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121907 · Cited by 7
Impact of Coronavirus Disease 2019 on Geriatric Psychiatry
Bankole, A. (2021) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2021.11.010 · Cited by 6
Comment on “ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank” by Kuo et al
Nikogosov, D. A., Shevlyakov, A., & Baranova, A. V. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa202 · Cited by 7
Lim, J. A., Thahir, A., Korde, V. A., & Krkovič, M. (2021) · PubMed Central · doi:10.22038/abjs.2020.50429.2502 · Cited by 7
Ramachandran, A. K., Das, S., Shenoy, G. G., Mudgal, J., & Joseph, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221226145141 · Cited by 7
Cui, Q., Jeyachandran, A. V., Garcia, G., Qin, C., Zhou, Y., Zhang, M., Wang, C., Sun, G., Liu, W., Zhou, T., et al. (2023) · MedComm · doi:10.1002/mco2.400 · Cited by 6
Coupling of Alzheimer’s Disease Genetic Risk Factors with Viral Susceptibility and Inflammation
Cao, C., Fu, G., Xu, R., & Li, N. (2023) · Aging and Disease · doi:10.14336/ad.2023.1017 · Cited by 8
Virtual day center for people with dementia and their caregivers during the COVID-19 pandemic
Maffioletti, V. L. R., Baptista, M. A. T., Abranches, B. J., Koatz, G., Marinho, V., Deslandes, A. C., & Dourado, M. C. N. (2021) · Dementia & Neuropsychologia · doi:10.1590/1980-57642021dn15-040003 · Cited by 7
Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative DiseasePreprint
Beach, T. G., Russell, A., Sue, L. I., Intorcia, A. J., Glass, M. J., Walker, J. E., Arce, R. A., Nelson, C. M., Hidalgo, T., Chiarolanza, G., et al. (2021) · medRxiv · doi:10.1101/2021.01.07.21249410 · Cited by 7
Zuniga, N. R., Earls, N. E., Denos, A. E. A., Elison, J. M., Jones, B. S., Smith, E. G., Moran, N. G., Broce, K. L., Romero, G. M., Hyer, C. D., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012407 · Cited by 9
Li, S., Sun, J., Li, H., Han, Z., Wang, T., Gao, S., Zhu, P., Chen, Y., Yan, P., Wang, M., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03006-z · Cited by 6
Ayyubova, G., Bablu, F. E., Rahimli, N., Aghayeva, L., Springer, E. M., Alghenaim, F., & Suzuki, Y. J. (2026) · Antioxidants · doi:10.3390/antiox15010066 · Cited by 8
Understanding the neurological implications of acute and long COVID using brain organoids
García‐González, L., Martí-Sarrias, A., Puertas, M. C., Bayón-Gil, Á., Resa‐Infante, P., Martínez‐Picado, J., Navarro, A., & Acosta, S. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050049 · Cited by 7
Kordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 6
Goldstein, M. R., & Cheslock, M. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110645 · Cited by 8
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
Pathak, G. A., Wendt, F. R., Goswami, A., Koller, D., Angelis, F. D., Initiative, C.-1. H. G., & Polimanti, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.698033 · Cited by 6
Thunell, J. A., Ferido, P., & Zissimopoulos, J. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18230 · Cited by 6
Prasad, K., Gour, P., Raghuvanshi, S., & Kumar, V. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.200 · Cited by 6
Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks
Pang, H., Frontera, J., Jiang, L., Li, C., Boutajangout, A., Sun, Z., Debure, L., Ghuman, M., Vedvyas, A., Masurkar, A. V., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71020 · Cited by 6
Influence of APOE locus on poor prognosis of COVID-19
Rodrigues, J. C. G., Pinto, P., Leitão, L. P. C., Vinagre, L. W. M. S., Monte, N., Fernandes, M. R., Khayat, A. S., de Assumpção, P. P., dos Santos, N. P. C., & dos Santos, S. E. B. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07379 · Cited by 5
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Jervies, J. L., King, S. P., & Suphioglu, C. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000475 · Cited by 5
Litvinenko, I., & Lobzin, V. Y. (2022) · Advances in Gerontology · doi:10.1134/s2079057022040117 · Cited by 5
Drug genetic associations with COVID-19 manifestations: a data mining and network biology approach
Charitou, T., Kontou, P. I., Tamposis, I., Pavlopoulos, G. A., Braliou, G. G., & Bagos, P. G. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00289-1 · Cited by 5
Circulating Chlamydia Trachomatis Antigens in Subjects With Alzheimer’s Disease
Lehrer, S. P., & Rheinstein, P. H. (2022) · In Vivo · doi:10.21873/invivo.12999 · Cited by 5
Ciurleo, G. C. V., Tavares-Júnior, J. W. L., Vieira, C. M. A. G., Braga‐Neto, P., & Oriá, R. B. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1229073 · Cited by 5
COVID-19: neurological sequelae
Spencer, P. S., Román, G. C., Buguet, A., Guekht, A. B., & Reis, J. J. (2021) · Health Risk Analysis · doi:10.21668/health.risk/2021.2.16 · Cited by 5
Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy
Zaki, M. O., Elsherbiny, D. A., Salama, M., & Azab, S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120267 · Cited by 6
Pastor, A. F., Docena, C., Rezende, A. M., Oliveira, F. R. D. S., Sena, M. D. A., de Morais, C. N. L., Bresani-Salvi, C. C., Vasconcelos, L. R. S., Valença, K. D. C., Araujo, C., et al. (2023) · Viruses · doi:10.3390/v15030645 · Cited by 5
Response to Comment on “ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank” by Kuo et al.
Kuo, C., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa198 · Cited by 5
Self-citationAssociation of ApoE isoforms with COVID-19 outcomes: a world-wide epidemiological study
Dhangadamajhi, G., Mishra, S., & Mukherjee, P. (2021) · Human Cell · doi:10.1007/s13577-021-00596-y · Cited by 5
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00004-2 · Cited by 6
Zorkina, Y., Syunyakov, T., Abramova, O. V., Andryushchenko, A., Andreyuk, D., Abbazova, E. V., Goncharov, D., Rakova, A., Andriushchenko, N., Gryadunov, D. A., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12102312 · Cited by 4
Biasetti, L., Zervogiannis, N., Shaw, K., Trewhitt, H., Serpell, L. C., Bailey, D., Wright, E., & Hall, C. N. (2024) · Open Biology · doi:10.1098/rsob.230349 · Cited by 3
Long-COVID olfactory dysfunction: allele E4 of apolipoprotein E as a possible protective factor
Oliveira, D. N., Tavares-Júnior, J. W. L., Feitosa, W. L. Q., Cunha, L. C. V., Gomes, C. M. P., Moreira-Nunes, C. A., da Silva, J. B. S., Sousa, A. V. M., Gaspar, S. D. B., Sobreira, E. S. T., et al. (2024) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0044-1788272 · Cited by 4
Influência da suscetibilidade genética na incidência e mortalidade de COVID-19 (SARS-CoV-2)
Galisa, S. L. G., Almeida, R. M. D. S., Soares, A. R. A. P., Ribeiro, R. R. A., Pereira, F. R. A., Gomes, K. A. L., de Oliveira, M. E. C., Nóbrega, W. F. S., Andrade, L. S. D. S., Santos, T. T. D. M., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11812 · Cited by 4
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19
Monllor, P., Kumar, P., Lloret, M.-Á., Ftara, A., Leon, J.-L., Lopez, B., Cervera‐Ferri, A., & Lloret, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230396 · Cited by 4
Clough, H. E., McIntyre, K. M., Patterson, G. E., Harris, J. P., & Rushton, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044707 · Cited by 4
Emmerson, C., Hollinghurst, J., North, L., Fry, R. J., Akbari, A., Humphreys, C., Gravenor, M. B., & Lyons, R. A. (2022) · Age and Ageing · doi:10.1093/ageing/afac250 · Cited by 4
Investigating the likely association between genetic ancestry and COVID-19 manifestationsPreprint
Das, R., & Ghate, S. D. (2020) · medRxiv · doi:10.1101/2020.04.05.20054627 · Cited by 5
HDL mimetics protect Alzheimer’s patients carrying APOE ε4 from SARS-CoV-2 invasion
Xu, R., Gao, J., Cao, C., Shi, M., Zhang, Y., Hong, S., Guo, S., Chen, M., Song, P., Fu, G., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102051 · Cited by 3
Genomic Landscape of Susceptibility to Severe COVID-19 in the Slovenian Population
Kovanda, A., Lukežič, T., Maver, A., Križaj, H. V., Sajko, M. Č., Šelb, J., Rijavec, M., Bidovec‐Stojkovič, U., Bitežnik, B., Rituper, B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147674 · Cited by 3
Flanagan, B. A., Fuess, L. E., Vrtílek, M., Roth-Monzón, A. J., & Bolnick, D. I. (2025) · Molecular Biology and Evolution · doi:10.1093/molbev/msaf323 · Cited by 3
Scuteri, D., Sakurada, S., Sakurada, T., Tonin, P., Bagetta, G., Nicotera, P., & Corasaniti, M. T. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220509152029 · Cited by 4
COVID-associated cognitive impairments: A review
Preobrazhenskaya, I. S. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.2.201512 · Cited by 3
Goldstein, M. R., & Mascitelli, L. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104785 · Cited by 3
Park, H., Oh, H. M., Kim, T., Kim, Y., Park, G., Hwang, H., & Im, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44080255 · Cited by 3
Best, L. G., Erdei, E., Haack, K., Kent, J. W., Malloy, K., Newman, D. E., O’Leary, M. A., O’Leary, R., Sun, Q., Navas‐Acién, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302464 · Cited by 3
PrabhuDas, M., Fuldner, R., Färber, D. L., Kuchel, G. A., Mannick, J. B., Nikolich‐Žugich, J., Sen, R., & Turner, J. (2021) · Nature Aging · doi:10.1038/s43587-021-00156-x · Cited by 3
Self-citationBergantin, L. B. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220504163811 · Cited by 3
Docosahexaenoic Acid Ester of Phloridzin Reduces Inflammation and Insulin Resistance via AMPK
Chen, J., Wu, Z., Wang, J., Si, X., Zhang, R., Sun, T., Dong, Q., Wu, W., & Qiu, Y. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220518102440 · Cited by 5
UKB.COVID19: an R package for UK Biobank COVID-19 data processing and analysis
Wang, L., Jackson, V. E., Fearnley, L. G., & Bahlo, M. (2021) · F1000Research · doi:10.12688/f1000research.55370.1 · Cited by 3
Carro, B. (2021) · All Life · doi:10.1080/26895293.2021.1977186 · Cited by 2
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms
Brock, S., Jackson, D., Soldatos, T. G., Hornischer, K., Schäfer, A., Diella, F., Emmert, M. Y., & Hoerstrup, S. P. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1035290 · Cited by 3
Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race
Goldstein, M. R., Poland, G. A., & Graeber, C. W. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.10.072 · Cited by 3
Genomic, proteomic biomarkers and risk factors associated with COVID-19
Singh, H., Nema, R., & Kumar, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824494-4.00018-7 · Cited by 2
Bratilova, E. S., Kachnov, V. A., Tyrenko, V. V., & Николаевна, К. С. (2022) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov87291 · Cited by 2
Evaluation of cognitive functions in a group of Egyptian recovered COVID-19 patients
Allam, H., Omar, A. E.-N. M., Sayed, M. M., Elbatrawy, A. N., Mohsen, N., Khalifa, A. G., & Ghobrial, F. F. (2023) · Middle East Current Psychiatry · doi:10.1186/s43045-023-00308-2 · Cited by 2
UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019
Feng, Q., Lacey, B., Bešević, J., Omiyale, W., Conroy, M. C., Starkey, F., Calvin, C. M., Callen, H., Bramley, L., Welsh, S., et al. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.18 · Cited by 2
Lima, W. D. S., Soares, M. H. P., Paschoal, E. H. A., Paschoal, J. K. S. F., Paschoal, F. M., & Bor‐Seng‐Shu, E. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1772834 · Cited by 2
Metadata
- Authors
- Kuo, C.-L., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Kuchel, G. A., & Melzer, D.
- Affiliations
- UConn Health (US)
- University of Exeter (GB)
- Corresponding author
- Melzer, David
- ORCID
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-26
- Volume
- 75
- Issue
- 11
- Pages
- 2231-2232
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC7314139
- OpenAlex
- W3031869734
- Cited by
- 388
- References
- 13
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 32 · 2023: 59 · 2022: 88 · 2021: 117 · 2020: 69
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journals of Gerontology Series A (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (R21AG060018)
- UK Medical Research Council (MR/S009892/1)
- National Institute for Health Research (DRF-2014-07-177)
- Department of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- APOE ε4, COVID-19 severity, Alzheimer's disease risk, dementia, delirium, rs429358, rs7412, genetic susceptibility, older adults, UK Biobank, community-based cohort, SARS-CoV-2, European ancestry, comorbidities, mortality risk, hospitalization risk
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, England, Female, Homozygote, Humans, Male, Pneumonia, Viral, Severity of Illness Index, Survival Analysis, Biological Specimen Banks, Coronavirus Infections, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein E4, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
